CS
OCDX

Credit Suisse’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Credit Suisse’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-102,136
Closed -$1.91M – 4593
2022
Q1 		$1.91M Buy
102,136
+13,110
+15% +$236K ﹤0.01% 2117
2021
Q4 		$1.9M Buy
89,026
+29,936
+51% +$590K ﹤0.01% 2827
2021
Q3 		$1.09M Buy
59,090
+3,768
+7% +$75.9K ﹤0.01% 3277
2021
Q2 		$1.19M Buy
+55,322
New +$1.12M ﹤0.01% 3254

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Credit Suisse's OCDX Position: Q2 2022 in Review

Credit Suisse sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 102,136 shares — an estimated $1.91M sold.

Credit Suisse first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $1.91M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Credit Suisse reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Credit Suisse sold 102,136 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.91M.
  • Credit Suisse first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
  • Credit Suisse's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.91M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.